Get started
INTEGRAL DIAGNOSTICS LIMITEDINTEGRAL DIAGNOSTICS LIMITEDINTEGRAL DIAGNOSTICS LIMITED

INTEGRAL DIAGNOSTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

IDX chart


Full chart

IDX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.12 B‬ AUD
Dividend yield (indicated)
1.93%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.26 AUD
Net income (FY)
‪−60.70 M‬ AUD
Revenue (FY)
‪469.70 M‬ AUD
Shares float
‪202.01 M‬
Beta (1Y)
−0.35

Employees


Employees (FY)
‪1.82 K‬
Change (1Y)
−21 −1.14%
Revenue / Employee (1Y)
‪257.79 K‬ AUD
Net income / Employee (1Y)
‪−33.31 K‬ AUD

About INTEGRAL DIAGNOSTICS LIMITED


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Ian Kadish
Website
integraldiagnostics.com.au
Headquarters
Melbourne
Founded
2008
ISIN
AU000000IDX2
FIGI
BBG00B2FTPW7
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. It operates under three core brands: Lake Imaging, South Coast Radiology, and Global Diagnostics. The company was founded in 1967 and is headquartered in North Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

IDX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IDX is 3.00 AUD — it has increased by 3.45% in the past 24 hours. Watch INTEGRAL DIAGNOSTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange INTEGRAL DIAGNOSTICS LIMITED stocks are traded under the ticker IDX.
IDX stock has fallen by −1.32% compared to the previous week, the last month showed zero change in price, over the last year INTEGRAL DIAGNOSTICS LIMITED has showed a 60.43% increase.
We've gathered analysts' opinions on INTEGRAL DIAGNOSTICS LIMITED future price: according to them, IDX price has a max estimate of 3.87 AUD and a min estimate of 3.00 AUD. Watch IDX chart and read a more detailed INTEGRAL DIAGNOSTICS LIMITED stock forecast: see what analysts think of INTEGRAL DIAGNOSTICS LIMITED and suggest that you do with its stocks.
IDX reached its all-time high on Jul 21, 2021 with the price of 5.47 AUD, and its all-time low was 1.03 AUD and was reached on Feb 15, 2017. View more price dynamics on IDX chart.
See other stocks reaching their highest and lowest prices.
IDX stock is 3.45% volatile and has beta coefficient of −0.35. Track INTEGRAL DIAGNOSTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is INTEGRAL DIAGNOSTICS LIMITED there?
Today INTEGRAL DIAGNOSTICS LIMITED has the market capitalization of ‪701.75 M‬, it has decreased by −3.61% over the last week.
Yes, you can track INTEGRAL DIAGNOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
INTEGRAL DIAGNOSTICS LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
IDX earnings for the last half-year are 0.05 AUD per share, whereas the estimation was 0.05 AUD, resulting in a −10.35% surprise. The estimated earnings for the next half-year are 0.04 AUD per share. See more details about INTEGRAL DIAGNOSTICS LIMITED earnings.
INTEGRAL DIAGNOSTICS LIMITED revenue for the last half-year amounts to ‪238.40 M‬ AUD, despite the estimated figure of ‪244.97 M‬ AUD. In the next half-year revenue is expected to reach ‪250.70 M‬ AUD.
IDX net income for the last half-year is ‪6.06 M‬ AUD, while the previous report showed ‪−66.76 M‬ AUD of net income which accounts for 109.07% change. Track more INTEGRAL DIAGNOSTICS LIMITED financial stats to get the full picture.
As of Dec 22, 2024, the company has ‪1.82 K‬ employees. See our rating of the largest employees — is INTEGRAL DIAGNOSTICS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTEGRAL DIAGNOSTICS LIMITED EBITDA is ‪89.89 M‬ AUD, and current EBITDA margin is 18.95%. See more stats in INTEGRAL DIAGNOSTICS LIMITED financial statements.
Like other stocks, IDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTEGRAL DIAGNOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTEGRAL DIAGNOSTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTEGRAL DIAGNOSTICS LIMITED stock shows the buy signal. See more of INTEGRAL DIAGNOSTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.